| For: | Yang B, Zhao XH, Ma GB. Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases 2022; 10(23): 8205-8211 [PMID: 36159531 DOI: 10.12998/wjcc.v10.i23.8205] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i23/8205.htm |
| Number | Citing Articles |
| 1 |
Jiao Meng, Wei Zhang, Hanmin Wang, Zihan He, Zhuxian Zhang. Progression of early diagnostic markers for diabetic kidney disease: From single-indicator detection to multi-omics integration modeling. Current Research in Physiology 2026; 9 doi: 10.1016/j.crphys.2026.100190
|
| 2 |
Yanyan Jiang, Jianhua Li, Juan Zhang, Sufang Chen. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1274025
|
| 3 |
Shuo Wang, Shengwu Chen, Yixuan Gao, Hongli Zhou. Bioinformatics led discovery of biomarkers related to immune infiltration in diabetes nephropathy. Medicine 2023; 102(35) doi: 10.1097/MD.0000000000034992
|
| 4 |
Kuldip Vyas, Abu Sufiyan Chhipa, Ayush chauhan, Snehal S. Patel. Pathophysiological mechanisms, potential biomarkers, and therapeutic interventions in diabetic nephropathy. Discover Molecules 2026; 3(1) doi: 10.1007/s44345-026-00071-x
|
| 5 |
Guido Gembillo, Luca Soraci, Giuseppe Spadaro, Rossella Messina, Felicia Cuzzola, Michela Calderone, Maria Federica Ricca, Simona Di Piazza, Flavia Sudano, Maria Elsa Gambuzza, Maria Princiotto, Lorenzo Lo Cicero, Domenico Santoro. Serum biomarkers in diabetic kidney disease: A comprehensive narrative review. World Journal of Diabetes 2026; 17(4): 113748 doi: 10.4239/wjd.v17.i4.113748
|
| 6 |
Roman Alekseienko, Volodymyr Markovskiy, Liubov Rysovana, Anton Shapkin, Mykola Lytvynenko, Olha Zaliubovska, Yuliia Avidzba. Study of the relationship between the level of pro-inflammatory cytokines and β2-microglobulin with indicators of changes in the functional status of the kidneys in diabetic nepropathy to determine the degrees of chronic renal failure. Wiadomości Lekarskie 2025; (2) doi: 10.36740/WLek/197132
|
| 7 |
Youlv Lu, Ruolin Fang, Bolun Xu, Chunyun Feng, Zhentao Zhu, Meiting Yu, Yuhua Tong. A semantic segmentation method to analyze retinal vascular parameters of diabetic nephropathy. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1494659
|
| 8 |
Lin Lin, Lin Yan, Nan Li, Yiru Wang, Yukun Luo. Reliable biomarkers for diabetic nephropathy using machine learning-assisted contrast-enhanced ultrasonography and clinical characteristics. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01837-2
|
| 9 |
Dongze Li, Li Zhang, Yanqiu He, Tingting Zhou, Xi Cheng, Wei Huang, Yong Xu. Novel histone post-translational modifications in diabetes and complications of diabetes: The underlying mechanisms and implications. Biomedicine & Pharmacotherapy 2022; 156 doi: 10.1016/j.biopha.2022.113984
|
| 10 |
Mihaela Gheorghiu, Maria-Florina Trandafir, Octavian Savu, Daniela Pasarica, Coralia Bleotu. Serum Behavior of NT-3 and VEGFβ, Two Unstudied Growth Factors in Patients with Diabetes Mellitus and End-Stage Renal Disease. Journal of Clinical Medicine 2025; 14(21) doi: 10.3390/jcm14217585
|
| 11 |
Jingfang Shao, Jinpeng Xu, Lili Zhou, Panruo Jiang. Close relationship between β2‐microglobulin and type 2 diabetes‐associated peripheral neuropathy. Journal of Diabetes Investigation 2026; doi: 10.1111/jdi.70413
|